El gran ensayo de la OMS no encuentra tratamientos efectivos para pacientes hospitalizados por la covid-19

by Agencia Sinc
  • 11 months ago

El estudio Solidarity, coordinado por la Organización Mundial de la Salud en más de 30 países, indica que las terapias con remdesivir, hidroxicloroquina, lopinavir/ritonavir e interferón no han te...

Read more

CNIO research team finds how melanoma deceives the immune system, increasing resistance to immunotherapy

by CNIO - Centro Nacional de Investigaciones Oncológicas

The sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, cancer being one of them. The immune system recognises and destroys cance...

Read more

AbilityPharma receives a 1.6 million euro grant from the FDA and opens a crowdfunding campaign in Capital Cell

by Ability Pharma

The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...

Read more

ORYZON Reports Results for Quarter Ended September 30, 2020 and Provides Corporate Update

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...

Read more

3P Biopharmaceuticals y SpyBiotech firman un contrato para la fabricación de vacunas

by 3P Biopharmaceuticals

3P Biopharmaceuticals, compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo normas de correcta fabricación (cGMPs) de medicamentos biológicos y productos de...

Read more

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

by Minoryx Therapeutics

Minoryx Therapeutics, a Phase 3 clinical stage biotech company focused on the development of differentiating treatment options in orphan central nervous system (CNS) disorders, today announces that th...

Read more

Pivotal to collaborate with Checkpoint Therapeutics on a study in patients with cutaneous squamous cell carcinoma​

by Pivotal

Pivotal announced today that it has been contracted by Checkpoint Th​erapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...

Read more

Oncoheroes Joins the Coalition Against Childhood Cancer (CAC2)

by Oncoheroes Biosciences

Oncoheroes today announced its organizational membership into the Coalition Against Childhood Cancer, known as CAC2, a collaborative network of organizations and individuals supporting and servicing t...

Read more

INTAS Develops COVID-19 Hyperimmune Globulin - A New Treatment

by Intas Pharma

The R&D team at Intas has developed a COVID-19 specific Hyperimmune Globulin as treatment for patients suffering from moderate to severe COVID-19infection. Hyperimmune Globulin also has potential for ...

Read more

New database measures gene activity in bacteria and their human hosts

by Centre for Genomic Regulation

Researchers and clinicians can use the database to further the development of new types of antibiotics.

Read more

ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream